Format

Send to

Choose Destination
Best Pract Res Clin Rheumatol. 2015 Jun;29(3):356-73. doi: 10.1016/j.berh.2015.08.002. Epub 2015 Oct 24.

Economic impact of musculoskeletal disorders (MSDs) on work in Europe.

Author information

1
The Work Foundation, Lancaster University, Bailrigg, Lancaster LA1 4YW, UK. Electronic address: sbevan@theworkfoundation.com.

Abstract

Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, 'presenteeism' and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.

KEYWORDS:

Early intervention; Employment; European Union; Musculoskeletal; Productivity; Sickness absence; Work disability

PMID:
26612235
DOI:
10.1016/j.berh.2015.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center